ICOA
ACHN

Investment Centers of America’s Achillion Pharmaceuticals ACHN Stock Holding History

Investment Centers of America’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-13,733
Closed -$57K – 667
2016
Q4 		$57K Hold
13,733
– – ﹤0.01% 603
2016
Q3 		$111K Hold
13,733
– – 0.01% 516
2016
Q2 		$107K Buy
13,733
+2,975
+28% +$25.5K 0.01% 483
2016
Q1 		$83K Buy
+10,758
New +$78.8K 0.01% 509

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Investment Centers of America's ACHN Position: Q1 2017 in Review

Investment Centers of America sold out of Achillion Pharmaceuticals (ACHN) in Q1 2017, closing a stake of 13,733 shares — an estimated $57K sold.

Investment Centers of America first reported a position in ACHN in Q1 2016 and held it in 4 quarters. The position peaked at $111K in Q3 2016. 130 funds tracked by Wall St. Rank hold ACHN as of Q1 2017.

  • Investment Centers of America reported no remaining Achillion Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Investment Centers of America sold 13,733 Achillion Pharmaceuticals shares in Q1 2017, an estimated $57K.
  • Investment Centers of America first reported a position in Achillion Pharmaceuticals in Q1 2016 and held it in 4 quarters.
  • Investment Centers of America's Achillion Pharmaceuticals position peaked at $111K in Q3 2016.
  • 130 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2017.

Based on Investment Centers of America's 13F filing for Q1 2017, filed 15 May 2017.